Quarterly report pursuant to Section 13 or 15(d)

OTHER INCOME - NET

v3.10.0.1
OTHER INCOME - NET
9 Months Ended
Aug. 31, 2018
OTHER INCOME - NET [Text Block]

NOTE 11 – OTHER INCOME - NET

Includes net gain on remeasurement of previously equity interest in Atvio and CureCell to acquisition date fair value in the amount of $4,509 and transaction costs related to GPP agreement in the amount of $1.5 million.